A. Noguerido

Triple-drug chemotherapy regimens in combination with an anti-EGFR agent in metastatic colorectal cancer - prospects from phase II clinical trials

J. Tabernero, I. Matos, E. Elez, 2019, Expert opinion on investigational drugs.

A Comprehensive Biomarker Analysis of Microsatellite Unstable/Mismatch Repair Deficient Colorectal Cancer Cohort Treated with Immunotherapy

R. Salazar, J. Tabernero, P. Nuciforo, 2022, International journal of molecular sciences.

Impact of circulating tumor DNA mutant allele fraction on prognosis in RAS‐mutant metastatic colorectal cancer

R. Salazar, Cristina Santos, J. Tabernero, 2019, Molecular oncology.

The safety of ramucirumab for the treatment of colorectal cancer

J. Tabernero, N. Mulet-Margalef, I. Matos, 2018, Expert opinion on drug safety.

Evaluating trifluridine + tipiracil hydrochloride in a fixed combination (TAS-102) for the treatment of colorectal cancer

J. Tabernero, G. Martini, I. Matos, 2018, Expert opinion on pharmacotherapy.